Inlexisertib;DCC-3116
Detalye ng Produkto
Mga Tag ng Produkto
| Laki ng Pack | Availability | Presyo (USD) |
Pangalan ng Kemikal:
4-(3-((2-((2-ethyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)propyl)-1,4 -oxazepan-5-isa
SMILES Code:
O=C1CCOCCN1CCCNC2=NC(NC3=C(CC)C=C(N4CCN(C)CC4)C=C3)=NC=C2C(F)(F)F
InChi Code:
InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21( 26(27,28)29)24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H,3- 4,7-16H2,1-2H3,(H2,30,31,32,33)
InChi Key:
CNBTYICEJGEABG-UHFFFAOYSA-N
Keyword:
2543673-19-2;CAS:2543673-19-2;CAS:2543673-19-2;DCC3116;DCC-3116;DCC 3116;Inlexisertib
Solubility:
Imbakan:Tuyo, madilim at nasa 0 -4 C para sa panandaliang panahon (araw hanggang linggo) o -20 C para sa pangmatagalan (buwan hanggang taon).
Paglalarawan:
Ang DCC-3116 ay isang oral active ULK1/2 inhibitor.
Target: ULK1/2







![1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5-[(5-fluoro-2,3-dihydro-4-benzofuranyl)methyl]-N8-methyl-N8-( 1-methyl-1H-pyrazol-4-yl)-](http://www.caerulumpharm.com/uploads/20240911145906.jpg)